These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 26513496)

  • 41. Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide.
    Shi Z; Fujii K; Kovary KM; Genuth NR; Röst HL; Teruel MN; Barna M
    Mol Cell; 2017 Jul; 67(1):71-83.e7. PubMed ID: 28625553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure of the HCV Internal Ribosome Entry Site Subdomain IIa RNA in Complex with a Viral Translation Inhibitor.
    Dibrov SM; Hermann T
    Methods Mol Biol; 2016; 1320():329-35. PubMed ID: 26227053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tricks an IRES uses to enslave ribosomes.
    Thompson SR
    Trends Microbiol; 2012 Nov; 20(11):558-66. PubMed ID: 22944245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ribosome-dependent conformational flexibility changes and RNA dynamics of IRES domains revealed by differential SHAPE.
    Lozano G; Francisco-Velilla R; Martinez-Salas E
    Sci Rep; 2018 Apr; 8(1):5545. PubMed ID: 29615727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGF-β2 Induces Ribosome Activity, Alters Ribosome Composition and Inhibits IRES-Mediated Translation in Chondrocytes.
    van den Akker GGH; Chabronova A; Housmans BAC; van der Vloet L; Surtel DAM; Cremers A; Marchand V; Motorin Y; Caron MMJ; Peffers MJ; Welting TJM
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A conserved RNA structure within the HCV IRES eIF3-binding site.
    Collier AJ; Gallego J; Klinck R; Cole PT; Harris SJ; Harrison GP; Aboul-Ela F; Varani G; Walker S
    Nat Struct Biol; 2002 May; 9(5):375-80. PubMed ID: 11927954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PSPC1 Binds to HCV IRES and Prevents Ribosomal Protein S5 Binding, Inhibiting Viral RNA Translation.
    Tripathi SK; Aneja A; Borgaonkar T; Das S
    Viruses; 2024 May; 16(5):. PubMed ID: 38793620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ensemble cryo-EM uncovers inchworm-like translocation of a viral IRES through the ribosome.
    Abeyrathne PD; Koh CS; Grant T; Grigorieff N; Korostelev AA
    Elife; 2016 May; 5():. PubMed ID: 27159452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutational analysis of the apical region of domain II of the HCV IRES.
    Kalliampakou KI; Psaridi-Linardaki L; Mavromara P
    FEBS Lett; 2002 Jan; 511(1-3):79-84. PubMed ID: 11821053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
    Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus.
    Lu HH; Wimmer E
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1412-7. PubMed ID: 8643645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA.
    Ji H; Fraser CS; Yu Y; Leary J; Doudna JA
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):16990-5. PubMed ID: 15563596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA.
    Boni S; Lavergne JP; Boulant S; Cahour A
    J Biol Chem; 2005 May; 280(18):17737-48. PubMed ID: 15760888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
    Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
    Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific interaction of a 25-kilodalton cellular protein, a 40S ribosomal subunit protein, with the internal ribosome entry site of hepatitis C virus genome.
    Fukushi S; Okada M; Kageyama T; Hoshino FB; Katayama K
    Virus Genes; 1999; 19(2):153-61. PubMed ID: 10541019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HCV IRES manipulates the ribosome to promote the switch from translation initiation to elongation.
    Filbin ME; Vollmar BS; Shi D; Gonen T; Kieft JS
    Nat Struct Mol Biol; 2013 Feb; 20(2):150-8. PubMed ID: 23262488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C IRES: translating translation into a therapeutic target.
    Jubin R
    Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural roles for human translation factor eIF3 in initiation of protein synthesis.
    Siridechadilok B; Fraser CS; Hall RJ; Doudna JA; Nogales E
    Science; 2005 Dec; 310(5753):1513-5. PubMed ID: 16322461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initiation factor-independent translation mediated by the hepatitis C virus internal ribosome entry site.
    Lancaster AM; Jan E; Sarnow P
    RNA; 2006 May; 12(5):894-902. PubMed ID: 16556939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.